Mirae Asset Global ETFs Holdings’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
31,001
-1,911
-6% -$68.8K ﹤0.01% 1435
2026
Q1
$807K Sell
32,912
-5,274
-14% -$125K ﹤0.01% 1621
2025
Q4
$947K Buy
38,186
+1,179
+3% +$31.3K ﹤0.01% 1550
2025
Q3
$1.05M Sell
37,007
-703
-2% -$19.1K ﹤0.01% 1464
2025
Q2
$938K Buy
37,710
+11,942
+46% +$336K ﹤0.01% 1474
2025
Q1
$799K Buy
25,768
+1,263
+5% +$42.1K ﹤0.01% 1605
2024
Q4
$773K Buy
24,505
+915
+4% +$43.5K ﹤0.01% 1690
2024
Q3
$1.37M Buy
23,590
+812
+4% +$39.9K ﹤0.01% 1361
2024
Q2
$924K Buy
+22,778
New +$903K ﹤0.01% 1501

Other funds holding ASTH

Mirae Asset Global ETFs Holdings's ASTH Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Astrana Health (ASTH) stake by 5.8% in Q2 2026, selling an estimated $68.8K and leaving 31,001 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

Mirae Asset Global ETFs Holdings first reported a position in ASTH in Q2 2024 and has held it in 9 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 31,001 shares of Astrana Health worth $1.44M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,911 Astrana Health shares in Q2 2026, an estimated $68.8K.
  • Astrana Health made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1435 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Astrana Health in Q2 2024 and has held it in 9 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.